BioNeutra Global Corporation (BGA) Fair Value & Analysis
Consumer Defensive · CA · Market cap C$1.4M
Fair value as of: Jun 26, 2026
From 7 valuation models · updated 4 days ago
Fair value updated Jun 26, 2026 — revised from C$0.0600 to C$0.0390 (−35.0%) since Jun 24, 2026.
Price vs Fair Value (12 months)
12‑month range C$0.0300 – C$0.0300 · fair‑value band C$0.0246 – C$0.0570 · the C$0.0300 price screens below the C$0.0390 fair value. As of Jun 26, 2026.
✦ Find undervalued quality stocks — 35,000+ analysed Find stocks →Analysis
BioNeutra Global Corporation (BGA) currently trades at C$0.0300, while our model-based Fair Value estimate is C$0.0390 — implying the stock looks roughly 30.0% undervalued today. We read business quality at 89/100 (high quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.
Over the trailing twelve months, BioNeutra Global Corporation generated revenue of C$10.9M at a net margin of -5.6%. Revenue grew 20.3% year over year. Net debt stands at C$5.6M. Fundamentals as of Jun 26, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 26, 2026. TTM = trailing twelve months.
About the company
BioNeutra Global Corporation engages in the research and development, production, and commercialization of food for nutraceutical, functional, and mainstream food and beverage products with a focus on oligosaccharides. The company offers isomalt oligosaccharide ingredients under the VitaFiber brand for human digestive health. It operates in Canada, the United States, Australia, New Zealand, European Union, and the Asia Pacific. The company is headquartered in Vancouver, Canada.
Revenue & earnings trend
FY2019 – FY2023 · reported fiscal years
BioNeutra Global Corporation reported revenue of C$11.4M in FY2023 versus C$37.7M in FY2019, a compound −25.9%/yr. Reported net income was −C$2.1M in FY2023.
Open the full interactive analysis →
Similar stocks
6 more Packaged Foods stocks, each showing price versus our Fair Value estimate (as of Jun 26, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Nestlé S.A NSRGF | $98.16 | $70.25 | -28% |
| Foshan Haitian Flavouring and Food Company 603288 | ¥35.10 | ¥25.34 | -28% |
| Nestlé India Limited NESTLEIND | ₹1,438 | ₹362.37 | -75% |
| Grupo Bimbo, S.A. BIMBOA | 57.10 MXN | 72.19 MXN | +26% |
| Uni-President Enterprises Corp 1216 | 75.10 TWD | 72.54 TWD | -3% |
| Britannia Industries Limited BRITANNIA | ₹5,218 | ₹3,567 | -32% |
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Frequently asked questions
Is BioNeutra Global Corporation (BGA) undervalued?
What is the fair value of BGA?
What is the quality score of BGA?
What is the revenue of BioNeutra Global Corporation (BGA)?
What is the net profit margin of BGA?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.